Exploratory Trial of TAS-303 in Female Patients With Stress Urinary Incontinence

NCT02906683 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

337

Enrollment

INDUSTRY

Sponsor class

Conditions

Stress Urinary Incontinence

Interventions

DRUG: TAS-303
DRUG: Placebo

Sponsor

Taiho Pharmaceutical Co., Ltd.